ALDH2 and cancer: Individuals with ALDH2 polymorphisms have a markedly reduced capacity to metabolize acetaldehyde, potentially leading to more complex and severe disease manifestations, such as malignant tumors, myocardial infarction, and dementia [14,15,16,17,18].